Shanghai Haoyuan Chemexpress Co. Ltd. A (688131) - Total Liabilities
Based on the latest financial reports, Shanghai Haoyuan Chemexpress Co. Ltd. A (688131) has total liabilities worth CN¥3.24 Billion CNY (≈ $474.35 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 688131 financial resilience to evaluate the company's liquid asset resilience ratio.
Shanghai Haoyuan Chemexpress Co. Ltd. A - Total Liabilities Trend (2013–2025)
This chart illustrates how Shanghai Haoyuan Chemexpress Co. Ltd. A's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Shanghai Haoyuan Chemexpress Co. Ltd. A total assets.
Shanghai Haoyuan Chemexpress Co. Ltd. A Competitors by Total Liabilities
The table below lists competitors of Shanghai Haoyuan Chemexpress Co. Ltd. A ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Betta Pharmaceuticals Co Ltd
SHE:300558
|
China | CN¥3.83 Billion |
|
Downer Edi Ltd
AU:DOW
|
Australia | AU$3.93 Billion |
|
North Industries Group Red Arrow Co Ltd
SHE:000519
|
China | CN¥8.03 Billion |
|
Rev Group Inc
NYSE:REVG
|
USA | $783.70 Million |
|
BankUnited Inc
NYSE:BKU
|
USA | $31.88 Billion |
|
Hang Zhou Iron & Steel Co Ltd
SHG:600126
|
China | CN¥13.92 Billion |
|
Shenzhen Everbest Machinery Indus
SHE:002980
|
China | CN¥981.23 Million |
|
CRRC Corporation Limited
F:C2L
|
Germany | €333.48 Billion |
Liability Composition Analysis (2013–2025)
This chart breaks down Shanghai Haoyuan Chemexpress Co. Ltd. A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 688131 net asset quality score to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.16 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.01 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.50 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shanghai Haoyuan Chemexpress Co. Ltd. A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shanghai Haoyuan Chemexpress Co. Ltd. A (2013–2025)
The table below shows the annual total liabilities of Shanghai Haoyuan Chemexpress Co. Ltd. A from 2013 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥-3.13 Billion ≈ $-458.54 Million |
-220.49% |
| 2024-12-31 | CN¥2.60 Billion ≈ $380.56 Million |
+56.11% |
| 2023-12-31 | CN¥1.67 Billion ≈ $243.78 Million |
+31.61% |
| 2022-12-31 | CN¥1.27 Billion ≈ $185.22 Million |
+130.93% |
| 2021-12-31 | CN¥548.11 Million ≈ $80.21 Million |
+66.58% |
| 2020-12-31 | CN¥329.03 Million ≈ $48.15 Million |
+130.49% |
| 2019-12-31 | CN¥142.75 Million ≈ $20.89 Million |
+12.56% |
| 2018-12-31 | CN¥126.82 Million ≈ $18.56 Million |
+64.83% |
| 2017-12-31 | CN¥76.94 Million ≈ $11.26 Million |
-22.54% |
| 2016-12-31 | CN¥99.34 Million ≈ $14.54 Million |
+137.62% |
| 2015-12-31 | CN¥41.80 Million ≈ $6.12 Million |
+72.14% |
| 2014-12-31 | CN¥24.28 Million ≈ $3.55 Million |
-2.06% |
| 2013-12-31 | CN¥24.80 Million ≈ $3.63 Million |
-- |
About Shanghai Haoyuan Chemexpress Co. Ltd. A
Shanghai Haoyuan Chemexpress Co., Ltd. researches, develops, and manufactures pharmaceutical intermediates and small molecule drugs. The company offers APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China.